These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 10308107)
1. Should government be the developer and disseminator of drug-use information? Johnson KW Drug Inf J; 1978; 12(1):53-5. PubMed ID: 10308107 [No Abstract] [Full Text] [Related]
2. The role of government in consumer drug information. Wolle JM Drug Inf J; 1977; 11(4):205-8. PubMed ID: 10307449 [No Abstract] [Full Text] [Related]
3. FDA-USP drug product problem reporting program--an update. Wheatley LS Hosp Formul; 1979 Mar; 14(3):359-60, 365. PubMed ID: 10316797 [No Abstract] [Full Text] [Related]
4. Government and drug information--the FDA. Groth PE Drug Inf J; 1978; 12(1):33-6. PubMed ID: 10308103 [No Abstract] [Full Text] [Related]
5. Drug information utilization--the need for government/industry communications. Gelberg A Drug Inf J; 1978; 12(3):163-6. PubMed ID: 10239113 [No Abstract] [Full Text] [Related]
6. Proposed government role in drug information. Spino M Drug Inf J; 1978; 12(1):26-8. PubMed ID: 10308101 [No Abstract] [Full Text] [Related]
7. Government as coordinator of drug information. Philbrook F Drug Inf J; 1978; 12(1):37-9. PubMed ID: 10316627 [No Abstract] [Full Text] [Related]
8. A survey of concepts and practices of drug information services. Ruger JR; Michelson PA Hosp Pharm; 1978 Feb; 13(2):90-2, 96, 98 passim. PubMed ID: 10306349 [No Abstract] [Full Text] [Related]
9. FDA electronic drug labels to improve patient safety. J Pain Palliat Care Pharmacother; 2006; 20(2):96-7. PubMed ID: 16789334 [No Abstract] [Full Text] [Related]
10. A golden opportunity. Weary PE J Am Acad Dermatol; 1980 Dec; 3(6):647-8. PubMed ID: 7204683 [No Abstract] [Full Text] [Related]
11. The Food and Drug Administration drug registration and listing system. Slavin M Drug Inf J; 1975; 9(2-3):239-40. PubMed ID: 10236978 [No Abstract] [Full Text] [Related]
12. Consultative services: they work in Minnesota. 1979 Arnold and Marie Schwartz Award winners. Welsh JS Am Pharm; 1979 Jul; 19(8):26-31. PubMed ID: 474400 [No Abstract] [Full Text] [Related]
13. A drug problem reporting system for Canadian hospital pharmacies. Friedel H; Gibson C Can J Hosp Pharm; 1978; 31(6):205-6. PubMed ID: 10240006 [No Abstract] [Full Text] [Related]
14. Irresponsible dissemination of drug information. Weston JK Drug Inf J; 1977; 11(3):153-7. PubMed ID: 10307437 [No Abstract] [Full Text] [Related]
15. The patient information and education initiative. Rheinstein PH; McGinnis TJ; Nightingale SL Am Fam Physician; 1995 Dec; 52(8):2377-8, 2381-2. PubMed ID: 7484726 [No Abstract] [Full Text] [Related]
16. Proposed legislation--its impact on drug information processing. Cleveland CB; Adams J Drug Inf J; 1978; 12(3):181-4. PubMed ID: 10239117 [No Abstract] [Full Text] [Related]
17. Pilot projects to stimulate adverse drug reaction reporting. Fincham JE J Clin Pharm Ther; 1987 Aug; 12(4):243-7. PubMed ID: 3624325 [TBL] [Abstract][Full Text] [Related]
18. Posted versus actual drug shortages. Bhat S; Roberts R; Devlin JW Am J Health Syst Pharm; 2012 Aug; 69(16):1363-4. PubMed ID: 22855099 [No Abstract] [Full Text] [Related]
19. Drug recalls and notification of practitioners. Rodts MF Orthop Nurs; 2004; 23(6):353-4. PubMed ID: 15682877 [No Abstract] [Full Text] [Related]
20. Investigational drug information is available to the pharmacist. Moore RC Am J Hosp Pharm; 1979 Nov; 36(11):1480, 1484. PubMed ID: 517531 [No Abstract] [Full Text] [Related] [Next] [New Search]